Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-04 LANCHBURY JERRY S Chief Scientific Officer Sale −19,360 $31.97 $619K 265,922
2021-05-04 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −19,360 68,640
2021-04-27 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion +40,000 $19.47 $779K 305,922
2021-04-27 LANCHBURY JERRY S Chief Scientific Officer Sale −40,000 $31.47 $1.3M 265,922
2021-04-27 LANCHBURY JERRY S Chief Scientific Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −40,000 88,000
2021-04-19 Lambert Nicole Sale −759 $27.01 $20K 135,009
2021-04-19 Lambert Nicole Sale −5,890 $27.01 $159K 129,119
2021-04-01 Santa Eric Chief Growth Officer Grant or award +16,420 16,420
2021-03-29 Hart Jayne B. Chief People Officer Exercise or conversion +28,000 $19.47 $545K 108,128
2021-03-29 Hart Jayne B. Chief People Officer Sale −28,000 $30.00 $840K 80,128
2021-03-29 Hart Jayne B. Chief People Officer Exercise or conversion +21,966 $24.89 $547K 102,094
2021-03-29 Hart Jayne B. Chief People Officer Sale −21,966 $30.00 $659K 80,128
2021-03-29 Hart Jayne B. Chief People Officer Exercise or conversion +8,034 $24.89 $200K 88,162
2021-03-29 Hart Jayne B. Chief People Officer Sale −8,034 $30.00 $241K 80,128
2021-03-29 Hart Jayne B. Chief People Officer Exercise or conversion · Incentive Stock Option (right to buy) −8,034 0
2021-03-29 Hart Jayne B. Chief People Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −28,000 0
2021-03-29 Hart Jayne B. Chief People Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −21,966 0
2021-03-24 Haas Kevin Richard Chief Technology Officer Grant or award +13,326 55,769
2021-03-24 Parkinson Paul EVP Strategy and Innovation Grant or award +10,661 87,407
2021-03-24 Jackson Benjamin E.V.P., General Counsel Grant or award +18,879 107,029

Page 28 of 35 · 689 trades